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Men’s help-seeking in the first year after diagnosis of localised prostate cancer
This study describes sources of support utilised by men with localised prostate cancer in the first year after
diagnosis and examines characteristics associated with help-seeking for menwith unmet needs. A cross-sectional
survey of 331 patients from a population-based sample who were in the first year after diagnosis (M = 9.6,
SD = 1.9) was conducted to assess sources of support, unmet supportive care needs, domain-specific quality of life
and psychological distress. Overall, 82% of men reported unmet supportive care needs. The top five needs were
sexuality (58%); prostate cancer-specific (57%); psychological (47%); physical and daily living (41%); and health
system and information (31%). Professional support was most often sought from doctors (51%). Across most
domains, men who were older (Ps ≤ 0.03), less well educated (Ps ≤ 0.04) and more depressed (Ps ≤ 0.05) were less
likely to seek help for unmet needs. Greater sexual help-seeking was related to better sexual function (P = 0.03),
higher education (P ≤ 0.03) and less depression (P = 0.05). Unmet supportive care needs are highly prevalent after
localised prostate cancer diagnosiswith older age, lower education and higher depression apparent barriers to help-
seeking. Interventions that link acrossmedicine, nursing and community based peer supportmay be an accessible
approach tomeeting these needs. Clinical Trial Registry: Trial Registration: ACTRN12611000392965.
Keywords: prostate cancer, supportive care needs, help-seeking, survivorship.
INTRODUCTION
Globally, over 1 million new cases of prostate cancer
were diagnosed in 2012 with 68% of these occurring in
more developed countries (Ferlay et al. 2014). Prostate
cancer incidence is highest in Australia/New Zealand,
North America, Western and Northern Europe (age
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standardised rates per 100 000 range from 85.0 to 111.6),
with incidence expected to increase globally to 1.7 mil-
lion cases in 2030 (Center et al. 2012; Ferlay et al.
2014). Survival rates for prostate cancer have increased
in most countries in the past two decades (Allemani
et al. 2015) such that in the UK, North America and
Australia/New Zealand approximately 90% of men now
survive their prostate cancer at least 5 years and >80%
survive for 10 years or more (Australian Institute of
Health and Welfare 2013; Cancer Research UK 2014;
American Cancer Society 2015). Although many more
men are surviving prostate cancer, they are living with
high and persistent symptom burdens often not
addressed in follow-up care (Smith et al. 2000; Bernat
et al. 2015; Carlsson et al. 2015; Gavin et al. 2015). In a
recent UK study, approximately one-third of men up to
2 years post-prostate cancer diagnosis reported concerns
with sexual, urinary and bowel function (Watson et al.
2015) and there is evidence to suggest that these effects
can persist for a decade or more (Bernat et al. 2015;
Carlsson et al. 2015). As well, men who were younger
or received multi-modal treatment including androgen
deprivation therapy (ADT) experienced worse effects
(Smith et al. 2007; Carlsson et al. 2015). In addition to
substantial symptom burden, prostate cancer survivors’
supportive care needs are frequently not met (Steginga
et al. 2001; Lintz et al. 2003; Smith et al. 2007; Cham-
bers et al. 2015a,b; Watson et al. 2015). Up to one half
of men report ongoing unmet sexuality, psychological,
and health system and information needs after prostate
cancer treatment (Steginga et al. 2001; Lintz et al. 2003;
Smith et al. 2007; Bernat et al. 2015; Watson et al.
2015).
Problematically, although prior studies suggest that
men access health care services (Holden et al. 2005,
2006) at similar frequencies to women (Hourani et al.
2016), they often do not actively seek help (or receive
treatment) for the full range of their concerns (Addis &
Mahalik 2003; Shabsigh et al. 2004; Galdas et al. 2005;
Steginga et al. 2008; Forsythe et al. 2013; Hyde et al.
2016; Yousaf et al. 2015) unless prompted to do so by a
partner or a direct enquiry from a health professional
(Holden et al. 2006). In particular, men with prostate
cancer are less likely to discuss their social and emo-
tional concerns with health care providers compared to
women with breast cancer (Forsythe et al. 2013). Rea-
sons for men’s hesitancy to seek help may include
under-reporting of emotional, physical or sexual con-
cerns (Kunkel et al. 2000; Holden et al. 2006; Bernat
et al. 2015; Yousaf et al. 2015); somatisation of mental
health symptoms (Kockler & Heun 2002; Fiske et al.
2009); self-reliance and a desire to maintain a sense of
normalcy (Gray et al. 2000; Yousaf et al. 2015); concerns
about burdening others (Gray et al. 2000); discomfort or
embarrassment (Yousaf et al. 2015); being less well edu-
cated or unaware (Dunn et al. 1999); and preference for
self-management (Klafke et al. 2014). However, although
recent studies have identified the symptom burden and
supportive care needs of prostate cancer survivors and
the factors that contribute to these (Smith et al. 2000;
McDowell et al. 2010, 2011; Bernat et al. 2015; Gavin
et al. 2015; Watson et al. 2015), patterns of help-seeking
in this population to address unmet needs are less well
described (Neese et al. 2003; Hyde et al. 2016). Rutten
et al. (2005) propose that cancer patient’s unmet needs
and sources of support should be examined with specific
reference to cancer survivorship stage (e.g., diagnosis,
treatment, post-treatment) in order to be responsive to
context. For prostate cancer survivors, unmet supportive
care needs are highest close to the time of treatment
(Smith et al. 2007; Harrison et al. 2009). Accordingly,
we describe men’s patterns of help-seeking in the first
year after prostate cancer treatment, their unmet sup-
portive care needs and from this examine factors related
to help-seeking in the context of unmet need.
METHODS
Recruitment
Men who were diagnosed with localised prostate cancer in
the state of Queensland, Australia were recruited between
September 2011 and November 2012 via the Queensland
Cancer Registry as part of a randomised controlled trial
that is ongoing (Chambers et al. 2011; Galv~ao et al. 2015).
Men were eligible for the trial if they had undergone/were
undergoing prostate cancer treatment; could read and
speak English; had no prior history of head injury, demen-
tia or current psychiatric illness; had no concurrent can-
cer; and received clearance to participate from their
physician. This study reports cross-sectional baseline data
from a sub-group of men drawn from the larger popula-
tion-based cohort who were in the first year after diagnosis
and had received treatment. The study was approved by
the Griffith University Human Research Ethics Commit-
tee and human research ethics committees of hospitals
across Queensland. All participants provided written
informed consent.
Measures
Baseline assessment occurred via computer-assisted tele-
phone interview using previously validated and reliable
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self-report measures (Chambers et al. 2011; Galv~ao et al.
2015).
Help-seeking and sources accessed
Help-seeking for prostate cancer-related concerns since
diagnosis was assessed using a self-report yes/no measure.
Type of help sought was measured with a prompted list on
which men indicated all resources (e.g. Internet, bro-
chures/books) and sources of support (e.g. doctor, nurse/
other health professional, family/friends, support group)
they had accessed for their concerns since diagnosis
(McDowell et al., 2011; Hyde et al. 2016). An open-ended
response option was provided for men to indicate if they
had used a resource or source of support that was not
listed.
Unmet supportive care needs
The Supportive Care Needs Survey Short Form-34 (SCNS-
SF34) measured men’s need for help across psychological,
health systems and information, patient care and support,
physical and daily living, and sexuality domains (Boyes
et al. 2009). A previously validated eight-item prostate
cancer-specific module was also included to assess uri-
nary, bowel, hormone and masculinity-related sexuality
(e.g. feeling like you’ve lost part of your manhood) needs
(Steginga et al. 2001). Items were rated 1 (no need/not
applicable), 2 (need was satisfied), 3 (low need), 4 (moder-
ate need) or 5 (high need).
Disease-specific quality of life
The domain summary scores from the Expanded UCLA
Prostate Index Composite (EPIC) was applied to measure
disease-specific quality of life for urinary (a = 0.85), bowel
(a = 0.87), sexual (a = 0.89) and hormonal (a = 0.69) func-
tion (Litwin et al. 1998; Wei et al. 2000). Scores for each
domain were transformed to a 0–100 scale with higher
scores indicating better functioning.
Distress
The Brief Symptom Inventory-18 (BSI-18) including
subscales of anxiety (a = 0.73), depression (a = 0.86) and
somatisation (a = 0.67) and a Global Severity Index
(GSI) (a = 0.88) assessed psychological distress (Dero-
gatis & Lopez 2000). Men reported the degree of dis-
tress experienced for each symptom in the week prior
to assessment, scored 0 (not at all) to 4 (extremely),
with higher scores indicating greater distress. Raw
scores were converted to standardised t-scores to iden-
tify men with clinically significant symptoms (Cham-
bers et al. 2014). Consistent with previous studies of
cancer patients, caseness was identified using a cut-off
t-score ≥57 on the BSI-18 GSI or on at least two of the
BSI-18 subscales (Zabora et al. 2001; Chambers et al.
2014).
Statistical analysis
Descriptive statistics were calculated for socio-demo-
graphic and treatment characteristics, and to describe psy-
chological distress, disease-specific quality of life, unmet
supportive care needs, help-seeking and sources of help
accessed. For men who expressed some level of need
(scored ≥3) overall and in each SCNS-SF34 domain (except
patient care and support because too few men reported an
unmet need on this domain), logistic regression was used
to examine associations between help-seeking and the fol-
lowing variables: age, education, months since diagnosis,
hormone treatment; BSI-18 somatic, depression, anxiety
subscales; and EPIC urinary, bowel and sexual domain
summary scores. The hormone summary score was not
included in the analysis due to the small number of men
who received ADT. Logistic regressions were also con-
ducted to examine associations between the variables
specified above and supportive care needs (except patient
care and support).
RESULTS
Recruitment and participant characteristics
Initially, 1899 patients were identified as potentially eligi-
ble for the trial and of these, 1770 doctors were contacted
for permission to recruit their patients of whom 88.4%
(n = 1564) gave consent to do so. Six hundred and seventy-
nine of 1501 patients contacted agreed to participate, of
which 463 met eligibility criteria, gave consent and com-
pleted baseline assessment (Galv~ao et al. 2015). Within
this group, 331 patients were in the first year after diagno-
sis and had received treatment for localised prostate
cancer. Analyses in this study are based on data from this
sub-group of men.
Mean age of men was 64.5 years (median = 65.0;
SD = 7.6). Most were in a relationship (86%), educated
at university/college (25%) or trade/technical (38%)
level, and just over half had an income ≥AUD $60 000.
Men were within the first 12 months of diagnosis (M =
9.6 months; median = 10.0; SD = 1.9). Men had
received treatment approximately 6 months prior to the
study (M = 6.4 months; median = 6.8; SD = 2.5), and
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most (68%) were treated with radical prostatectomy
(Table 1).
Disease-specific quality of life
Table 1 reports EPIC domain summary scores and of
these men reported few difficulties in the areas of urinary
and bowel function and hormonal effects. By contrast,
sexual function scores were lower. Specifically, 41% of
men considered their sexual function to be a moderate/
big problem in the month prior to baseline assessment;
with 14.2% and 4.5% reporting urinary and bowel dys-
function, respectively, to be a moderate/big problem in
the same time frame. Sixty-four men received ADT and
of these approximately 10% identified hot flushes,
depression and body weight as a moderate/big problem.
Lack of energy was a moderate/big problem for 22% of
these men.
Psychological distress
The standardised mean BSI GSI was 45.5 (SD = 8.5, range
36–72), with mean subscale scores of 47.4 for somatisation
(SD = 6.8, range 42–81), 46.3 for depression (SD = 7.2,
range 42–77) and 45.2 for anxiety (SD = 7.5, range 39–72).
Forty-two men (12.7%) were identified as reaching high
distress using the cut-off specified (t-score ≥57).
Unmet supportive care needs
Overall, 82% of men had some (low, moderate or high)
level of need across any supportive care need domains. Of
these, over half had concerns about sexuality (58%) and
prostate cancer-specific needs (57%) that were not
addressed. Approximately, half reported psychological
(47%) and physical and daily living (41%) needs, and less
than one-third had health system and information (31%)
or patient care and support (17%) needs. Moderate–high
need was expressed most frequently on sexuality (40%)
and prostate cancer-specific (34%) domains (Table 2). The
top 10 items for which men reported moderate to high
unmet needs are described in Table 2. Of these, sexuality
needs caused the most concern or discomfort with approx-
imately one-third of men reporting they needed help with
changes in sexual feelings and relationships and their
sense of masculinity (feeling like a man). Physical needs,
particularly not being able to do things as before, lack of
energy/tiredness, and urinary incontinence were moder-
ate–high concerns for ≥10% of men. Men also expressed
moderate–high need for help with their own (10%) or close
others’ (12%) psychological well-being, and their feelings
of uncertainty about the future (9%). A moderate–high
information need regarding being informed about things
to do to get well was reported by 9% of men. Table 3
shows that men who experienced increased anxiety or
somatic symptoms and were treated with ADT (vs. not
treated) were more likely to express unmet supportive care
needs across a range of need areas. Better outcomes on sex-
ual, urinary and bowel domains and older age were associ-
ated with less unmet needs (Table 3). Education and
months since diagnosis were not related to unmet needs.
Help-seeking and sources of support accessed
Overall, 94% of men reported that they had accessed
resources and/or support for their prostate cancer-related
Table 1. Patient socio-demographic and treatment characteris-
tics and EPIC domain summary scores (N = 331)
Characteristics Mean (SD)/range or %
Age (years) 64.5 (7.6)/44–89
Education (highest level completed)
University or college degree 25.4
Trade/technical certificate/diploma 38.4
Senior high school 10.0
Junior high school 19.9
Primary school 6.0
Did not complete primary school 0.3
Marital status
Married 81.6
Defacto 3.9
Divorced/separated 4.5
Widowed 1.2
Single 8.8
Gross household income (AUD)
< $20 000 11.2
$20 000 to $39 999 23.0
$40 000 to $59 999 14.2
$60 000 to $79 999 12.7
$80 000+ 35.6
Don’t know/unwilling to answer 3.3
Months since diagnosis 9.6 (1.9)/2.9–12.5
Months since treatment 6.4 (2.5)/0.1–11.3
Treatment received
Radical prostatectomy 68.9
EBRT with ADT 13.0
EBRT without ADT 2.7
Brachytherapy with ADT 2.1
Brachytherapy without ADT 5.4
EBRT & Brachytherapy with ADT 1.5
ADT only 2.7
Other 3.6
EPIC domain summary scores
Urinary 85.3 (15.6)
Bowel 93.1 (11.0)
Hormonal 80.6 (13.9)
Sexual 36.0 (22.6)
ADT, androgen deprivation therapy; AUD, Australian dollars;
EBRT, external beam radiation therapy; EPIC, expanded prostate
cancer incidence composite.
4 of 12 © 2016 The Authors. European Journal of Cancer Care Published by John Wiley & Sons Ltd.
HYDE ET AL.
Table 2. Supportive care needs domains and items (SCNS SF-34) (N = 331)
Supportive care needs*,† Some need %
No need or need
satisfied % Low need %
Moderate–high
need %
Physical and daily living need 40.5 59.5 18.1 22.4
Not being able to do the things you used to do 24.8 75.2 10.3 14.5‡
Lack of energy/tiredness 24.8 75.2 14.8 10.0‡
Feeling unwell a lot of the time 8.7 91.3 3.0 5.7
Work around the home 8.5 91.5 4.9 3.6
Pain 6.6 93.4 3.0 3.6
Psychological need 47.1 52.9 23.0 24.1
Concerns about the worries of those
close to you
23.0 77.0 11.2 11.8‡
Fears about the cancer spreading 21.5 78.5 12.7 8.8
Uncertainty about the future 21.1 78.9 12.1 9.0‡
Feeling down or depressed 17.5 82.5 7.3 10.2‡
Anxiety 15.7 84.3 7.3 8.4
Feelings of sadness 15.4 84.6 7.8 7.6
Worry that the results of treatment are
beyond your control
14.2 85.8 7.3 6.9
Learning to feel in control of your situation 12.4 87.6 6.9 5.5
Feelings about death or dying 9.1 90.9 5.8 3.3
Keeping a positive outlook 8.2 91.8 3.9 4.3
Health system and information need 30.8 69.2 10.3 20.5
Being informed about things you can do to
help yourself get well
14.5 85.5 5.5 9.0‡
Having one member of staff with whom
you can talk to about all aspects of your
condition, treatment and follow-up
13.0 87.0 4.5 8.5
Having access to professional counselling
(e.g. psychologist, social worker, counsellor,
nurse specialist) if you, family or friends need it
10.9 89.1 4.5 6.4
Being given information (written, diagrams, drawings)
about aspects of managing your illness and side effects
at home
9.4 90.6 4.2 5.2
Being given explanations of those tests for which you
would like explanations
9.1 90.9 3.6 5.5
Being adequately informed about cancer which is under
control or diminishing
8.8 91.2 2.4 6.4
Being adequately informed about the benefits and side
effects of treatments before you choose to have them
8.5 91.5 2.4 6.1
Being informed about your test results as soon as feasible 7.3 92.7 2.1 5.2
Being given written information about the important
aspects of your care
5.8 94.2 1.6 4.2
Being treated like a person not just another case 5.7 94.3 1.8 3.9
Being treated in a hospital or clinic that is as physically
pleasant as possible
3.6 96.4 2.1 1.5
Patient care and support need 16.7 83.3 6.7 10.0
Reassurance by medical staff that the way you feel is
normal
8.5 91.5 4.3 4.2
More choice about which cancer specialists you see 6.4 93.6 1.8 4.6
More choice about which hospital you attend 6.1 93.9 2.1 4.0
Hospital staff attending promptly to your physical needs 5.4 94.6 2.7 2.7
Hospital staff acknowledging, and showing sensitivity
to, your feelings and emotional needs
2.4 97.6 0.6 1.8
Sexuality need 58.0 42.0 17.8 40.2
Changes in sexual feelings 47.7 52.3 18.7 29.0‡
Changes in sexual relationships 41.4 58.6 13.0 28.4‡
To be given information about sexual relationships 19.9 80.1 9.0 10.9‡
Prostate cancer-specific need 57.4 42.6 23.0 34.4
Feeling like you’ve lost part of your manhood 38.1 61.9 16.0 22.1‡
Urinary incontinence 26.0 74.0 12.7 13.3‡
Problems with your bowel habits 11.5 88.5 4.8 6.7
Hot flushes§ 6.9 93.1 3.1 3.8
Difficulties in passing urine 6.6 93.4 3.6 3.0
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concerns. Excluding resources accessed, 79.5% reported
seeking support while 20.5% did not access any form of
support. Breaking this down further to examine seeking
support from a health professional (doctor, nurse, coun-
selling, or cancer helpline), 61% reported seeking support
while 39% did not seek any support from health profes-
sional(s) for prostate cancer-related concerns. The most
common resources accessed were brochures or books from
the doctor (78%) and the Internet (53%). Sources of sup-
port most frequently accessed by men since their prostate
cancer diagnosis were a doctor (51%) and family or friends
(48%). Local nurse counsellors, cancer helpline, and coun-
selling services and libraries were rarely accessed. While
prostate cancer support group use was not high, it was sub-
stantially more than other types of counselling services
(Table 4).
Associations between help-seeking and unmet
supportive care needs
Associations between socio-demographic and treatment
characteristics, disease-specific quality of life, psychologi-
cal distress, and help-seeking for men who had some level
of need overall and on each supportive care needs domain
were examined and results of the logistic regressions are
displayed in Table 5. Men who expressed some level of
need overall (n = 272) were less likely to seek help if they
were older (OR 0.94, CI 0.89–0.99), limited to high school
(OR 0.25, CI 0.09–0.74) or primary school (OR 0.07, CI
0.02–0.28) level education and had increased depression
symptoms (OR 0.83, CI 0.70–0.98). Being older (OR 0.88,
CI 0.80–0.98) and those limited to primary school level
education (OR 0.14, CI 0.02–0.90) were associated with a
lower likelihood of seeking help for physical and daily liv-
ing needs. Men who had psychological or health system
and information needswere less likely to seek help if they
had not progressed beyond primary school level educa-
tion (ORPsychological 0.09, CI 0.02–0.51; ORHealthSystInfo
0.06, CI 0.01–0.64) and increased depression symptoms
(ORPsychological 0.71, CI 0.57–0.87; ORHealthSystInfo 0.77, CI
0.60–1.00). As well, there was a trend for older men with
unmet health system and information needs to seek help
less often (0.91, CI 0.83–1.00, P = 0.057). Men with
unmet sexuality needs were less likely to seek help if
they were educated at high school (OR 0.24, CI 0.07–
0.90) or primary school (OR 0.10, CI 0.02–0.57) level,
more time had passed since diagnosis (OR 0.72, CI 0.53–
0.97), they experienced more depression symptoms (OR
0.81, CI 0.66–1.00), and had better bowel function (OR
0.93, CI 0.87–1.00, P = 0.056), with help-seeking also
associated with better sexual function (OR 1.03, CI 1.00–
1.06). Being older (OR 0.92, CI 0.86–0.99), educated not
further than primary school level (OR 0.08, CI 0.02–0.42),
and increased depression (OR 0.83, CI 0.68–1.00) were
associated with less help-seeking for men with prostate
cancer-specific needs.
DISCUSSION
The present study confirms previous research over the
past decade showing a high prevalence of unmet support-
ive care needs in men with localised prostate cancer (Steg-
inga et al. 2001; Lintz et al. 2003; Smith et al. 2007;
Watson et al. 2015). Hence, despite the development of
clinical practice guidelines for men with prostate cancer
(National Health and Medical Research Council 2003;
American Urological Association 2007; Australian Cancer
Network Management of Metastatic Prostate Cancer
Working Party 2010; Parker et al. 2015) and generic guide-
lines for psychosocial care in oncology (National Compre-
hensive Cancer Network 2002; National Breast Cancer
Centre and National Cancer Control Initiative 2003; Hol-
land et al. 2011), the pattern of need is unremitting and
sexuality needs in particular appear intransigent. These
findings have implications moving forward given the
recent focus on prostate cancer survivorship guidelines
(Skolarus et al. 2014; Resnick et al. 2015) and the observa-
tion that knowing what might assist men and actually
Table 2. Continued
Supportive care needs*,† Some need %
No need or need
satisfied % Low need %
Moderate–high
need %
Feeling that what you say is
not taken seriously by others
9.4 90.6 4.5 4.9
Feeling as if you are going through a change of life like
women do§
3.4 96.6 1.1 2.3
Feeling like you have lost the ability to be aggressive 2.4 97.6 1.2 1.2
*Level of need for help in the last month.
†Need was scored 1–2 = no need/need satisfied, 3 = some need, 4–5 = moderate–high need.
‡Top 10 moderate–high supportive care need.
§n = 262 (69 men receiving androgen deprivation therapy were excluded).
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moving this into practice are different questions (Deane
2014).
In this regard, although men may access health care ser-
vices and do so more frequently as they age, this may not
equate to help-seeking for reproductive health concerns
such as erectile dysfunction (Holden et al. 2005, 2006). In
a population-based study of close to 6000 Australian men,
21% reported moderate to severe erectile dysfunction and
of these 30% had spoken to a health professional about
their condition, with this proportion decreasing by age
(17% of men aged ≥70 years had discussed their concerns)
(Holden et al. 2005, 2006). Prostate cancer survivors are
also less likely to raise their concerns with health care pro-
viders (Forsythe et al. 2013), and in particular discuss sex-
ual concerns much less frequently in follow-up care than
concerns about urinary or bowel function (Watson et al.
2015). This creates a challenge for health professionals in
terms of how to best identify men with unmet needs and
provide accessible support. As well it indicates a need for
health care professionals to initiate discussion with men
about sexuality irrespective of whether sexual concerns
are expressed (Holden et al. 2006; Forsythe et al. 2013).
The top three sources of support accessed by men in the
present study were the medical professional, nurse and to
a lesser extent prostate cancer support groups. These three
points of support may present as a triad that if well linked
and resourced may have the greatest potential for making
a difference in men’s unmet needs after prostate cancer
diagnosis and treatment. Family and friends as a preferred
source of support may also help to promote men’s aware-
ness and encourage help-seeking from available health
and supportive care services (Holden et al. 2006; Smith
et al. 2006). As well, the high utilisation of the Internet
points to this as a key resource that could be leveraged to
improve access to self-management tools as well as profes-
sional support.
Men who were older, less well educated and more
depressed were less likely to seek help despite having
unmet needs for support. For age, this may relate to mas-
culine values around stoicism and self-reliance that may
be more strongly held by older men (Chambers et al.
2015a,b) and suggests the importance of continuing to
understand the unique challenges faced by specific
sub-groups of men. Level of education likely reflects
health literacy that is especially problematic given low
health literacy is also related to poorer health outcomes
(DeWalt et al. 2004) and poorer use of health services
(Berkman et al. 2011). For example, in a population-based
study of Australian men, lower levels of functional health
literacy were associated with obstructive sleep apnoea and
comorbidities including sedentary lifestyle, depression
and cardiovascular disease (Li et al. 2014). The relation-
ship between higher depression and not seeking help
speaks to the need for regular assessment of psychosocial
needs (Forsythe et al. 2013) including systematic distress
screening, rather than waiting for distressed men to self-
present (Chambers et al. 2014). Finally, help-seeking was
associated with better sexual function and this may reflect
that men who sought help had better outcomes. Alterna-
tively, it may suggest that men were more likely to seek
support for sexuality needs if they had better sexual func-
tion. This latter interpretation is consistent with prior
research suggesting severity of erectile dysfunction deters
help-seeking such that sexuality interventions may
require tailoring to sexual function (Hyde et al. 2016).
Strengths of this study include a large cohort of men
drawn from a population-based cancer registry; the use of
valid and reliable measures; and addressing the knowl-
edge-gap regarding associations between supportive care
needs and help-seeking. Limitations include the cross-
sectional design which precludes inferences about causal-
ity, and retrospective self-report assessment of help-seek-
ing. Longitudinal assessment of supportive care needs for
men with localised and advanced prostate cancer and
their patterns of help-seeking are a key focus for future
research.
CONCLUSION
The diagnosis and treatment of prostate cancer is followed
by well-described supportive care needs that are frequently
unmet and this was apparent in the current study, particu-
larly for sexuality needs. Few men accessed the range of
health professional and community support options avail-
able and men with greatest need were least likely to seek
support. Older age, lower education, and depression are
risk factors for men not seeking help. A new approach to
Table 4. Resources and sources of support accessed since
diagnosis (N = 331)
Help accessed %
Resources
Brochures or books from doctor 77.6
Internet 52.6
Brochures or books from family/friends 7.3
Library 2.7
Sources of support
Doctor 50.8
Family/friends 48.0
Nurse/Other health professional 17.8
Prostate cancer support group 7.9
Cancer Helpline 4.5
Counselling service 2.1
Local nurse counsellors 0.0
8 of 12 © 2016 The Authors. European Journal of Cancer Care Published by John Wiley & Sons Ltd.
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supportive care for men with prostate cancer seems war-
ranted that links across medicine, nursing and commu-
nity-based peer support. Future research is needed to
establish the optimal mode for intervening to reduce the
morbidity associated with this disease.
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